Literature DB >> 7636455

Infectious asthma: a reemerging clinical entity?

D L Hahn1.   

Abstract

BACKGROUND: In the primary care setting, patients often report that their asthma began after an acute respiratory infection such as bronchitis, pneumonia, or an influenza-like illness ("infectious asthma"). Preceding respiratory illnesses such as bronchitis and pneumonia are also epidemiologic correlates of asthma in both children and adults. These associations suggest the possibility that respiratory infection is involved in the initiation of asthma in addition to the already acknowledged role of infection in asthma exacerbations. The purpose of this study was to investigate whether a history of infectious asthma influenced clinical and pulmonary function characteristics of patients with chronic asthma.
METHODS: Conducted in a community-based primary care practice, this is a clinical descriptive study of 92 middle-class patients who had a mean age of 37.7 years (standard deviation 15.4 years), a clinical diagnosis of chronic asthma, and baseline pulmonary function test results available for analysis.
RESULTS: There was sufficient history available to classify asthma as infectious in 41 (45%) of 92 patients. Patients with infectious asthma reported a much shorter duration of asthma symptoms than did patients with atopic, occupational, and exercise-induced asthma (5.6 vs 13.3 years, P = .001). Nevertheless, patients with infectious asthma had significantly worse percentages of predicted FEV1 and FEF25%-75%, both before and after bronchodilator therapy.
CONCLUSIONS: Infectious asthma was common in this primary care setting. Compared with patients with other asthma syndromes, those with infectious asthma had worse pulmonary function despite a shorter duration of symptomatic disease. Further studies of the cause and prognosis of this clinical entity are warranted.

Entities:  

Mesh:

Year:  1995        PMID: 7636455

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  7 in total

Review 1.  Asthma in children: are chlamydia or mycoplasma involved?

Authors:  S Esposito; N Principi
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Epidemiology of Infections and Development of Asthma.

Authors:  Jenny Resiliac; Mitchell H Grayson
Journal:  Immunol Allergy Clin North Am       Date:  2019-04-30       Impact factor: 3.479

3.  Secondary outcomes of a pilot randomized trial of azithromycin treatment for asthma.

Authors:  David L Hahn; Mary Beth Plane; Olaimatu S Mahdi; Gerald I Byrne
Journal:  PLoS Clin Trials       Date:  2006-06-30

Review 4.  Infection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides.

Authors:  Wilmore C Webley; David L Hahn
Journal:  Respir Res       Date:  2017-05-19

5.  Chronic infection with Chlamydia pneumoniae in asthma: a type-2 low infection related phenotype.

Authors:  Doriane Calmes; Pascale Huynen; Virginie Paulus; Monique Henket; Françoise Guissard; Catherine Moermans; Renaud Louis; Florence Schleich
Journal:  Respir Res       Date:  2021-02-26

6.  Infectious Asthma: An Easily Identified Clinical Presentation with Implications for Diagnosis, Prognosis, Treatment, and Prevention of Asthma.

Authors:  David L Hahn; Nikki M Schultek
Journal:  J Asthma Allergy       Date:  2022-09-09

7.  Outcomes of Antibiotics in Adults with "Difficult to Treat" Asthma or the Overlap Syndrome.

Authors:  Fred A Wagshul; Doris T Brown; Nikki M Schultek; David L Hahn
Journal:  J Asthma Allergy       Date:  2021-06-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.